Lind Global Fund II LP 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 4:30 pm Purchase | 2022-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Lind Global Fund II LP | 11,137 3.800% | 11,137 (New Position) | Filing |